Market Snapshot
S&P Futures
4,132.75
Dow Futures
32,794
Nasdaq Futures
13,103.75
Seelos Therapeutics, Inc. (SEEL) stock declined over -9.97% intraday to trade at $0.9002 a share on NASDAQ. The stock opened with a loss of -4.23% at $0.97 and touched an intraday high of $1.04, falling -9.98% against the last close of $1. The stock went to a low of $0.9 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-08 | $0.97 | $1.04 | $0.9 | $0.9 | 1,184,558 |
2022-08-05 | $0.94 | $1.03 | $0.94 | $1 | 922,800 |
2022-08-04 | $0.91 | $1 | $0.9 | $0.97 | 692,700 |
2022-08-03 | $0.86 | $0.92 | $0.86 | $0.9 | 416,100 |
2022-08-02 | $0.88 | $0.89 | $0.85 | $0.87 | 369,300 |
2022-08-01 | $0.84 | $0.9 | $0.84 | $0.85 | 366,000 |
2022-07-29 | $0.88 | $0.89 | $0.84 | $0.84 | 260,100 |
2022-07-28 | $0.87 | $0.9 | $0.85 | $0.87 | 383,600 |
2022-07-27 | $0.89 | $0.89 | $0.83 | $0.84 | 495,600 |
2022-07-26 | $0.89 | $0.89 | $0.87 | $0.88 | 327,200 |
Employees-
Beta2.46
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
Seelos Therapeutics, Inc. (NASDAQ: SEEL) stock price is $0.9002 as of the last check on Monday, August 8. During the trading session, SEEL stock reached the peak price of $1.04 while $0.9 was the lowest point it dropped to.
The NASDAQ listed SEEL is part of Pharmaceuticals industry that operates in the broader Health Care sector. Seelos Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders.
Dr. Raj Mehra J.D., Ph.D.
Founder, Chairman, CEO & Pres
Mr. Michael J. Golembiewski
Chief Financial Officer
Ms. Kimberly Farrand
Sr. Director of Clinical Devel. & Operations
Mr. Anthony Marciano
Chief Communications Officer
SEEL stock traded closed the last session at $0.9, which is -$0.09970000000000001 or -9.970997099709972% lower than its previous close of $1. SEEL's current trading price is 87.42% lower than its 52-week high of $2.79 where as its distance from 52-week low of 0.48% is -67.73%.
Number of SEEL employees currently stands at -. SEEL operates from 300 Park Avenue, 2nd Floor, New York, NY 10022, United States.
Official Webiste of $SEEL is: https://seelostherapeutics.com
SEEL could be contacted at SEEL operates from 300 Park Avenue, 2nd Floor, New York, NY 10022, United States, or at phone #646 293 2100 and can also be accessed through its website.
SEEL stock volume for the day was 1,218,314 shares while in the previous session number of SEEL shares traded was 1,184,558 . The average number of SEEL shares traded daily for last 3 months was 1.2 Million.
The percentage change in SEEL stock occurred in the recent session was -9.970997099709972% while the dollar amount for the price change in SEEL stock was -$0.09970000000000001.
In the recent session, the day high for SEEL stock was $1.04 while the low for SEEL stock touched on the day was $0.9.
The market value of SEEL currently stands at 92.9 Million with its latest stock price at $0.9002 and 105.53 Million of its shares outstanding.